Algenex is developing internally as well as in collaboration with several independent research institutions a number of subunit recombinant vaccines against different animal and human pathogens.
The most advanced developments at this time are those against Rabbit Hemorrhagic Virus Disease (RHDV), Porcine Circovirus, Bovine Viral Diarrhea (BVD), Human Papilloma virus and Influenza virus.
The three animal health vaccines have been tested in susceptible animals with excellent results and each of the five vaccine development projects indicated above are currently available for Licensing or Partnering discussions.
